A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Ixekizumab Sustains High Level of Efficacy and Favorable Safety Profile Over 4 Years in Patients With Moderate Psoriasis: Results From UNCOVER‐3 Study

(2019) M G Lebwohl et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Systematic Review on Rapidity of Onset of Action for Interleukin‐17 and Interleukin‐23 Inhibitors for Psoriasis

(2019) Alexander Egeberg et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial

(2019) Kristian Reich et al.   LANCET

Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey

(2019) Joe Gorelick et al.   Dermatology and Therapy

Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: An integrated analysis from 11 clinical trials

(2018) R G Langley et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review

(2018) Mwangi Murage et al.   Patient Preference and Adherence

Biologics and Psoriasis

(2018) Hee J. Kim et al.   DERMATOLOGIC CLINICS

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

(2017) Andrew Blauvelt et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3

(2017) C.L. Leonardi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians

(2016) J. M. Carrascosa et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Clinical meaningfulness of complete skin clearance in psoriasis

(2016) Bruce Strober et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

(2016) Kenneth B. Gordon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient-relevant treatment goals in psoriasis

(2015) Christine Blome et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice

(2015) Steven R. Feldman et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Psoriasis

(2015) Wolf-Henning Boehncke et al.   LANCET

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

(2015) Christopher E M Griffiths et al.   LANCET

Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis

(2014) Hema N. Viswanathan et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

(2014) Mark G. Lebwohl et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PASI90 response: the new standard in therapeutic efficacy for psoriasis

(2014) L. Puig   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course

(2011) R.B. Warren et al.   BRITISH JOURNAL OF DERMATOLOGY

The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups

(2009) Denise Globe et al.   Health and Quality of Life Outcomes

Patients’ perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study

(2008) B Amatya et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY